Contact Chinese Japanese
DNAVEC Corporation
 
会社案内
事業概要
用語解説
プレスリリース
リンク
トップページ

News & Media Releases

Important DNAVEC related news

Date Media Content
31.03.06
-
DNAVEC and Eisai Sign an Agreement on Drug Discovery Research for Vaccine Therapy for Alzheimer's Disease
16.01.06
-
DNAVEC took out a patent for "AIDS virus vaccines using Sendai virus vector" in China
15.11.05
Nikkei News
Development of HIV vaccines using Sendai virus vector in China, Clinical trial in 2006
13.10.05
Nikkei News & others
The first gene therapy with a Sendai virus vector in Japan, MHLW approved Kyushu University's plan
24.08.05
Nikkei Industrial
Changing stream in medical therapy with vaccines including those based on Sendai virus vectors
29.06.05
Nikkei Industrial
DNAVEC took basic patents of Sendai virus vectors in major countries
17.06.05
Nikkei Industrial
DNAVEC and Medical & Biological Laboratories Co., Ltd (MBL) founded a joint corporation in Beijing, China
09.06.05
Nikkei News
DNAVEC and National Institute for Longevity Sciences will aim at development of intranasal vaccines for Alzheimer's disease therapy
13.04.05
-
DNAVEC announces the launch of "CKD Cancer Gene Therapy Consortium" among 3 parties (Chiba University, Kyusyu University and DNAVEC) and the opening of a center for the program contributed by DNAVEC
13.04.05
Nikkei Industrial
DNAVEC's Joint Research with two universities in the field of cancer gene therapy
11.04.05
Nikkei Industrial
Social Lounges "Social Lounges: "Surviving by multinational expansion" said Mamoru Hasegawa, President of DNAVEC
17.02.05
Nikkei Industrial & Nikkei Biotech DNAVEC announces execution of Joint Research Agreement on the development of gene medicines with Kringle Pharma, Inc
07.12.04
-
DNAVEC announces business alliance with Medical & Biological Laboratories Co., Ltd (MBL) on the use of Sendai virus vector
01.12.04 - DNAVEC announces execution of agreement on licensing-out of gene therapy formulation to Beijing Pharmaceutical Group Co.
07.10.04 Nikkei News
Dream Incubator undertook a capital increase. DNAVEC raised one thousand nine hundred million yen
01.05.04 Weekly Toyo Economy Hideaki Sena "Invited Seat for Science" - 2nd (Monthly), Today's guest Mamoru Hasegawa, President of DNAVEC, said "Gene therapy will be felt like flu-drugs"
13.04.04 - DNAVEC Announces the Launch of "CKD Cancer Gene Therapy Consortium" Among 3 Parties (Chiba University, Kyusyu University and DNAVEC) and the Opening of a Center for the Program Contributed by DNAVEC.
07.11.03 Nikkei News An AIDS vaccine, Japanese and Chinese collaborative development, DNAVEC Res. Inc. received an effective gene
07.07.03 Nikkei Industrial New bio-business developed by Sendai virus vectors. Safer gene therapy, Clinical trial plans in Japanese and overseas universities.
26.06.03 Nikkei News DNAVEC Res. Inc. developed "carrier" of genes (North Kanto VB file)
13.06.03 Nikkei News DNAVEC Res. Inc., SARS vaccine construction trial till Aug, Collaboration with Beijing Univ. Technol., Animal experiment in China
26.08.02 Nikkei Biotech DNAVEC Res. Inc. gained a grant for CF gene therapy using Sendai virus vectors
03.09.01 Daily Yakuji DNAVEC Res. Inc., Developed a new viral vector for gene therapy of critical limb ischemia
02.08.01 Nikkei Industrial News DNAVEC Res. Inc., Gene transfer into monkey ES cells, Vector 90% effective
20.07.01 Nikkei News DNAVEC Res. Inc., Effective in gene therapy, Developed a "carrier", Clinical trial in UK
02.07.01 Nikkei Biotech Kyushu Univ. constructed a research consortium using DNAVEC's Sendai virus vectors
05.02.01 Nikkei News DNAVEC Res. Inc., Developed a Japanese original vector
18.11.00 Nikkei News Gene therapy, Accelerated to commercialization, Target life-style related diseases
25.09.00 Nikkei News DNAVEC Res. Inc., Japanese original development, High performance gene carrier